Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lunn

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer riskG L David-Beabes, R M Lunn, S J London
Carcinogenesis|September 2, 1999
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)R M Lunn, D A Bell, J L Mohler, et al.
Journal of Leukocyte Biology|May 1, 1989
Induction of proteins in interferon-alpha- and interferon-gamma-treated polymorphonuclear leukocytesB Y Rubin, S L Anderson, R M Lunn, et al.
Cancer Research|June 11, 1999
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequencyR M Lunn, R G Langlois, L L Hsieh, et al.
Journal of Biological Response Modifiers|October 1, 1989
Fragmentation of cellular DNA is a nonspecific indicator of responsiveness to tumor necrosis factorB Y Rubin, S L Anderson, R M Lunn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer riskM C Stern, D M Umbach, C H van Gils, et al.
Journal of Interferon Research|October 1, 1988
The development of antibody to the interferon-induced indoleamine 2,3-dioxygenase and the study of the regulation of its synthesisB Y Rubin, S L Anderson, G R Hellermann, et al.
Journal of Virology|June 1, 1988
Production of a monoclonal antibody directed against an interferon-induced 56,000-dalton protein and its use in the study of this proteinB Y Rubin, S L Anderson, R M Lunn, et al.
Cancer Research|November 1, 1988
Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factorB Y Rubin, L J Smith, G R Hellermann, et al.
Carcinogenesis|April 7, 2000
XPD polymorphisms: effects on DNA repair proficiencyR M Lunn, K J Helzlsouer, R Parshad, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer riskG L David-Beabes, R M Lunn, S J London
Carcinogenesis|September 2, 1999
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)R M Lunn, D A Bell, J L Mohler, et al.
Journal of Leukocyte Biology|May 1, 1989
Induction of proteins in interferon-alpha- and interferon-gamma-treated polymorphonuclear leukocytesB Y Rubin, S L Anderson, R M Lunn, et al.
Cancer Research|June 11, 1999
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequencyR M Lunn, R G Langlois, L L Hsieh, et al.
Journal of Biological Response Modifiers|October 1, 1989
Fragmentation of cellular DNA is a nonspecific indicator of responsiveness to tumor necrosis factorB Y Rubin, S L Anderson, R M Lunn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer riskM C Stern, D M Umbach, C H van Gils, et al.
Journal of Interferon Research|October 1, 1988
The development of antibody to the interferon-induced indoleamine 2,3-dioxygenase and the study of the regulation of its synthesisB Y Rubin, S L Anderson, G R Hellermann, et al.
Journal of Virology|June 1, 1988
Production of a monoclonal antibody directed against an interferon-induced 56,000-dalton protein and its use in the study of this proteinB Y Rubin, S L Anderson, R M Lunn, et al.
Cancer Research|November 1, 1988
Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factorB Y Rubin, L J Smith, G R Hellermann, et al.
Carcinogenesis|April 7, 2000
XPD polymorphisms: effects on DNA repair proficiencyR M Lunn, K J Helzlsouer, R Parshad, et al.
Pageof 2